FUKUDA, N., TODA, K., FUJIWARA, Y., WANG, X., OHMOTO, A., URASAKI, T., . . . TAKAHASHI, S. (2020). Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib. In Vivo.
Chicago ZitierstilFUKUDA, NAOKI, et al. "Neutrophil-to-Lymphocyte Ratio As a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib." In Vivo 2020.
MLA ZitierstilFUKUDA, NAOKI, et al. "Neutrophil-to-Lymphocyte Ratio As a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib." In Vivo 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.